Therefore, future studies to identify additional novel targets of miR-361-3p and other miRNAs that can also regulate SH2B1 will allow us to have deep understanding of the mechanisms underlying the development and progression of NSCLC. The gene discussed is SH2B1; the disease is non-small cell lung carcinoma.